Ciprofloxacin 250mg tablets

Ülke: Birleşik Krallık

Dil: İngilizce

Kaynak: MHRA (Medicines & Healthcare Products Regulatory Agency)

Aktif bileşen:

Ciprofloxacin hydrochloride

Mevcut itibaren:

Bristol Laboratories Ltd

ATC kodu:

J01MA02

INN (International Adı):

Ciprofloxacin hydrochloride

Doz:

250mg

Farmasötik formu:

Oral tablet

Uygulama yolu:

Oral

Sınıf:

No Controlled Drug Status

Reçete türü:

Valid as a prescribable product

Ürün özeti:

BNF: 05011200; GTIN: 5060013940439

Bilgilendirme broşürü

PACKAGE LEAFLET: INFORMATION FOR THE USER
CIPROFLOXACIN 100 MG TABLETS
CIPROFLOXACIN 250 MG TABLETS
CIPROFLOXACIN 500 MG TABLETS
CIPROFLOXACIN 750 MG TABLETS
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING
THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT
INFORMATION FOR YOU.
•
Keep this leaflet. You may need to read again.
•
If you have any further questions, ask your doctor or
pharmacist.
•
This medicine has been prescribed for you only. Do
not pass it on to others. It may harm them, even if
their signs of illness are the same as yours.
•
If you get any side effects, talk to your doctor or
pharmacist. This includes any possible side effects
not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1. What Ciprofloxacin tablets are and what they are
used for
2. What you need to know before you take
Ciprofloxacin tablets
3. How to take Ciprofloxacin tablets
4. Possible side effects
5. How to store Ciprofloxacin tablets
6. Contents of the pack and other information
1. WHAT CIPROFLOXACIN TABLETS ARE AND
WHAT THEY ARE USED FOR
The active substance is Ciprofloxacin. Ciprofloxacin is an
antibiotic belonging to the fluoroquinolone family.
Ciprofloxacin works by killing bacteria that cause infec-
tions. It only works with specific strains of bacteria.
_ADULTS_
Ciprofloxacin is used in adults to treat the following
bacterial infections:
•
respiratory tract infections
•
long lasting or recurring ear or sinus infections
•
urinary tract infections
•
genital tract infections in men and women
•
gastro-intestinal tract infections and intra-abdominal
infections
•
skin and soft tissue infections
•
bone and joint infections
•
to prevent infections due to the bacterium _Neisseria_
_meningitidis_
•
anthrax inhalation exposure
Ciprofloxacin may be used in the management of patients
with low white blood cell counts (neutropenia) who have
a fever that is suspected to be due to a bacterial infection.
If you have a severe infection or one that is caused by more
than one type of bacterium, you may

Ürün özellikleri

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Ciprofloxacin 250mg Tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains Ciprofloxacin 250mg (as hydrochloride)
For the full list of excipients, see section 6.1
3
PHARMACEUTICAL FORM
Film-coated tablet
White to creamish white round film-coated tablets- debossed "CPR 100"
on one side and
"BL" on the reverse.
4.1
THERAPEUTIC INDICATIONS
Ciprofloxacin 100mg film-coated tablets are indicated for the
treatment of the following
infections (see sections 4.4 and 5.1). Special attention should be
paid to available
information on resistance to ciprofloxacin before commencing therapy.
Consideration should be given to official guidance on the appropriate
use of antibacterial
agents.
_Adults _
•
Lower respiratory tract infections due to Gram-negative bacteria
-
Exacerbations of chronic obstructive pulmonary disease. In
exacerbation of chronic
obstructive
pulmonary
disease
Ciprofloxacin
should
be
used
only
when
it
is
considered
inappropriate
to
use
other
antibacterial
agents
that
are
commonly
recommended for the treatment of these infections.
-
Broncho-pulmonary infections in cystic fibrosis or in bronchiectasis
-
Pneumonia
•
Chronic suppurative otitis media
•
Acute exacerbation of chronic sinusitis especially if these are caused
by Gram-
negative bacteria
•
Urinary tract infections
-
Uncomplicated acute cystitis. In uncomplicated acute cystitis
Ciprofloxacin should
be used only when it is considered inappropriate to use other
antibacterial agents
that are commonly recommended for the treatment of these infections.
-
Acute pyelonephritis
-
Complicated urinary tract infections
-
Bacterial prostatitis
•
Genital tract infections
- Gonococcal uretritis and cervicitis due to susceptible _Neisseria
gonorrhoeae_
- Epididymo-orchitis including cases due to susceptible _Neisseria
gonorrhoeae_
-Pelvic
inflammatory
disease
including
cases
due
to
susceptible
_Neisseria _
_gonorrhoeae_
•
Infections of the gastro-intestinal tract (e.g. travelle